A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)

Clinical trial NCT00978250 · COMPLETED

Trial details

NCT number: NCT00978250
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms Lung Neoplasms Urinary Bladder Neoplasms Breast Neoplasms

Start date: 2009-08-20
Primary completion: 2019-04-11
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.